Health Care & Life Sciences » Pharmaceuticals | JW Pharmaceutical Corp.

JW Pharmaceutical Corp. | Ownership

Companies that own JW Pharmaceutical Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
280,541
1.42%
-165
0%
07/31/2018
BlackRock Fund Advisors
170,876
0.87%
0
0%
09/05/2018
Dimensional Fund Advisors LP
133,878
0.68%
9,880
0%
04/30/2018
Norges Bank Investment Management
100,746
0.51%
25,965
0%
12/31/2017
Mirae Asset Global Investments Co., Ltd.
86,771
0.44%
-2,374
0.03%
04/30/2018
BlackRock Advisors (UK) Ltd.
47,364
0.24%
0
0%
09/05/2018
Northern Trust Investments, Inc.
18,256
0.09%
0
0%
09/07/2018
Charles Schwab Investment Management, Inc.
13,578
0.07%
0
0%
09/06/2018
SSgA Funds Management, Inc.
7,478
0.04%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
7,139
0.04%
0
0%
03/31/2018

About JW Pharmaceutical

View Profile
Address
JW Tower
Seoul SL 06725
Korea, Republic Of
Employees -
Website http://www.jw-pharma.co.kr
Updated 07/08/2019
JW PHARMACEUTICAL Corp. engages in the development, manufacture, and sale of pharmaceuticals. Its products include analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, antifungal agents, circulatory system agents, gastrointestinal agents, miscellaneous, multivitamins and anti-anemic agents, contact lens care and ophthalmic agents, topicals, amino acid solutions, flexible intravenous container, intravenous solutions, respiratory agents, obstetrics and gynecology agents, nephrology agents, central nervous system, urology agents, and diabetic agents. The company was founded on August 8, 1945 and is headquartered in Seoul, South Korea.